levonorgestrel has been researched along with tranexamic acid in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andersch, B; Andersson, K; Milsom, I; Rybo, G | 1 |
| Duckitt, K; Shaw, RW | 1 |
| Prentice, A | 1 |
| Cameron, IT; Irvine, GA | 1 |
| Phupong, V; Sophonsritsuk, A; Taneepanichskul, S | 1 |
| Chi, C; Kadir, RA | 1 |
| Fernandez, H; Gervaise, A | 1 |
| Fraser, IS; Kouides, PA; Lukes, AS; Porte, RJ | 1 |
| Loisel, C; Marpeau, L; Puscasiu, L; Roman, H; Sentilhes, L | 1 |
| Agostini, A; Bazot, M; Brailly-Tabard, S; Brun, JL; Chabbert-Buffet, N; Cravello, L; De Raucourt, E; Fauconnier, A; Fernandez, H; Gervaise, A; Golfier, F; Gompel, A; Gondry, J; Graesslin, O; Huchon, C; Lucot, JP; Marret, H; Plu-Bureau, G; Roman, H | 1 |
| Daniels, J; Gray, R; Gupta, J; Kai, J; Middleton, L; Pattison, H | 1 |
| Soper, DE | 1 |
| Draeby, J; Inki, P; O'Flynn, M; Schmelter, T; Sørdal, T | 1 |
| Bitzer, J; Calaf-Alsina, J; Fraser, IS; Heikinheimo, O; Nelson, AL | 1 |
| Barton, P; Daniels, JP; Gray, R; Gupta, JK; Kai, J; Middleton, LJ; Pattison, HM; Prileszky, G; Roberts, TE; Sanghera, S | 1 |
| Friedlander, E; Kaneshiro, B | 1 |
| Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G | 1 |
| Evliyaoglu, O; Haberal, A; Kayikcioglu, F; Kiseli, M | 1 |
| Barton, P; Bhattacharya, S; Horne, AW; Roberts, TE; Sanghera, S | 1 |
| Bistervels, IM; Hamulyák, EN; Middeldorp, S; Scheres, LJJ | 1 |
| Alexander Gerds, T; Kuhr Skals, R; Lidegaard, O; Meaidi, A; Torp-Pedersen, C | 1 |
| Bofill Rodriguez, M; Jordan, V; Lethaby, A | 1 |
| Guthmann, R; Halajian, E; Lale, A; Nashelsky, J | 1 |
13 review(s) available for levonorgestrel and tranexamic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fortnightly review. Medical management of menorrhagia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 1999 |
Medical management of dysfunctional uterine bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptives, Oral, Combined; Danazol; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 1999 |
Women and von Willebrand disease: controversies in diagnosis and management.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Contraceptives, Oral, Synthetic; Deamino Arginine Vasopressin; Endometrium; Female; Genital Diseases, Female; Humans; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Tranexamic Acid; von Willebrand Diseases | 2006 |
[Dysfunctionnal uterin bleedings].
Topics: Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Pregnancy; Premenopause; Tranexamic Acid; Uterine Hemorrhage | 2007 |
A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Danazol; Deamino Arginine Vasopressin; Female; Gonadotropin-Releasing Hormone; Hemostatics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Risk Assessment; Tranexamic Acid | 2008 |
Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Coagulation Disorders; Contraceptives, Oral, Combined; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvis; Prevalence; Tranexamic Acid; Ultrasonography | 2010 |
Medical management of heavy menstrual bleeding: a comprehensive review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 2015 |
Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraception; Doxycycline; Female; Hormone Antagonists; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Matrix Metalloproteinase Inhibitors; Mifepristone; Practice Guidelines as Topic; Time Factors; Tranexamic Acid; Uterine Hemorrhage | 2015 |
Role of Medical Management for Uterine Leiomyomas.
Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins | 2016 |
Sex matters: Practice 5P's when treating young women with venous thromboembolism.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low-Molecular-Weight; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Risk Factors; Sex Factors; Stockings, Compression; Thrombophilia; Thrombophlebitis; Tranexamic Acid; Travel; Uterine Hemorrhage; Venous Thromboembolism; Young Adult | 2019 |
Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Antifibrinolytic Agents; Contraceptives, Oral; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Norethindrone; Progesterone; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid; Treatment Outcome | 2020 |
Which medications work best for menorrhagia?
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Danazol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Menorrhagia; Tranexamic Acid; Young Adult | 2020 |
5 trial(s) available for levonorgestrel and tranexamic acid
| Article | Year |
|---|---|
The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use.
Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Drug Implants; Female; Humans; Levonorgestrel; Metrorrhagia; Prospective Studies; Tranexamic Acid | 2006 |
Levonorgestrel intrauterine system versus medical therapy for menorrhagia.
Topics: Adult; Antifibrinolytic Agents; Contraceptive Agents, Female; Estrogens; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Middle Aged; Progestins; Quality of Life; Severity of Illness Index; Sexual Behavior; Tranexamic Acid | 2013 |
Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Prospective Studies; Tranexamic Acid | 2013 |
A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Female; Cost-Benefit Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Primary Health Care; Quality-Adjusted Life Years; Surveys and Questionnaires; Technology Assessment, Biomedical; Tranexamic Acid; Treatment Outcome | 2015 |
Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study.
Topics: Adult; Anemia; Female; Hemostatics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norethindrone; Reproductive Control Agents; Tranexamic Acid | 2016 |
11 other study(ies) available for levonorgestrel and tranexamic acid
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Topics: Adult; Female; Flurbiprofen; Hemoglobins; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Norgestrel; Tranexamic Acid | 1991 |
Is medical management of menorrhagia obsolete?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Estrogen Replacement Therapy; Female; Humans; Hysteroscopy; Laparoscopy; Levonorgestrel; Mefenamic Acid; Menorrhagia; Middle Aged; Norethindrone; Progesterone Congeners; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid | 1998 |
[Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Hormonal; Embolization, Therapeutic; Endometrial Hyperplasia; Estrogens; Female; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Levonorgestrel; Metrorrhagia; Polyps; Pregnancy; Progestins; Tranexamic Acid; Uterine Neoplasms; Uterus | 2008 |
The intrauterine device: a good thing revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Pelvic Inflammatory Disease; Tamoxifen; Tranexamic Acid | 2013 |
Pharmaceutical treatments to prevent recurrence of endometriosis following surgery: a model-based economic evaluation.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Models, Economic; Primary Health Care; Quality-Adjusted Life Years; Secondary Prevention; Tranexamic Acid; Treatment Outcome | 2016 |
Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION SUMMARY, Number 785.
Topics: Adolescent; Antifibrinolytic Agents; Blood Coagulation Disorders; Contraceptive Agents; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 2019 |
Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785.
Topics: Adolescent; Antifibrinolytic Agents; Blood Coagulation Disorders; Contraceptive Agents; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progestins; Tranexamic Acid | 2019 |
Decline in Danish use of oral tranexamic acid with increasing use of the levonorgestrel-releasing intrauterine system: a nationwide drug utilization study.
Topics: Adolescent; Adult; Denmark; Drug Utilization; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menorrhagia; Middle Aged; Progestins; Tranexamic Acid; Young Adult | 2020 |
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Endometrial Ablation Techniques; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Tranexamic Acid; Uterine Artery Embolization; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms; Watchful Waiting | 2021 |